Sculptor Capital
ELV icon

Sculptor Capital’s Elevance Health ELV Stock Holding History

Sculptor Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-84,500
Closed -$10.1M – 772
2014
Q3 		$10.1M Sell
84,500
-1,100
-1% -$126K 0.03% 384
2014
Q2 		$9.21M Hold
85,600
– – 0.03% 414
2014
Q1 		$8.52M Sell
85,600
-10,700
-11% -$968K 0.03% 409
2013
Q4 		$8.9M Sell
96,300
-36,600
-28% -$3.25M 0.02% 477
2013
Q3 		$11.1M Buy
132,900
+80,400
+153% +$6.89M 0.03% 435
2013
Q2 		$4.3M Buy
+52,500
New +$3.93M 0.01% 506

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Sculptor Capital's ELV Position: Q3 2017 in Review

Sculptor Capital sold out of Elevance Health (ELV) in Q3 2017, closing a stake of 430,389 shares — an estimated $81M sold.

Sculptor Capital first reported a position in ELV in Q3 2013 and held it in 5 quarters. The position peaked at $192M in Q1 2017. 845 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Sculptor Capital reported no remaining Elevance Health position as of Q3 2017 after selling out during the quarter.
  • Sculptor Capital sold 430,389 Elevance Health shares in Q3 2017, an estimated $81M.
  • Sculptor Capital first reported a position in Elevance Health in Q3 2013 and held it in 5 quarters.
  • Sculptor Capital's Elevance Health position peaked at $192M in Q1 2017.
  • 845 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Sculptor Capital's 13F filing for Q3 2017, filed 13 Nov 2017.